Tops & Flops Stocks
Security ▲ | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Acadia Pharmaceuticals | 0.380% | 1.153% | -4.964% | -20.628% | -44.384% | -8.831% | -32.457% |
Acceleron Pharma Inc. | - | - | - | - | - | - | - |
Agios Pharmaceuticals Inc. | -3.110% | 1.307% | 21.094% | 33.621% | 50.485% | -32.211% | -30.657% |
Alnylam Pharmace. | 2.170% | 6.377% | 1.199% | -25.442% | -18.955% | 30.706% | 117.678% |
Amicus Therapeutics Inc. | -3.550% | - | - | - | - | - | - |
Arena Pharmaceuticals Inc | - | - | - | - | - | - | - |
Arrowhead Pharmaceuticals Inc. | -0.640% | 9.571% | -2.353% | -38.093% | -17.472% | -57.420% | 43.865% |
Bluebird Bio Inc. | 2.630% | 12.437% | -16.515% | -76.124% | -24.284% | -96.229% | - |
Blueprint Medicines Corp | 2.250% | 17.936% | 19.357% | 88.785% | 22.424% | 30.694% | - |
Catalent Inc. | 0.340% | 0.459% | 0.401% | 21.246% | 27.573% | -40.610% | 26.957% |
Charles River Labs Intl | 0.960% | 1.524% | -5.948% | 26.649% | 3.192% | -22.057% | - |
Emergent Biosolutions Inc. | 8.400% | 132.380% | 95.476% | -47.101% | 84.246% | -91.900% | -90.646% |
Exelixis Inc. | -0.390% | -7.458% | -4.728% | 15.037% | -6.993% | -1.405% | 12.555% |
Fibrogen Inc. | 12.750% | 34.144% | -15.400% | -91.968% | 47.558% | -92.369% | - |
Genomic Health | -2.270% | - | - | - | - | - | - |
Global Blood Therapeutics Inc | - | - | - | - | - | - | - |
Halozyme Therapeutics Inc. | 1.500% | 4.955% | 1.161% | 36.393% | 13.264% | -1.969% | - |
Immunomedics Inc. | - | - | - | - | - | - | - |
Invitae Corp | -78.840% | - | - | - | - | - | - |
Ionis Pharmaceuticals Inc. | -2.650% | -1.475% | -4.585% | 21.120% | -16.619% | 26.764% | -37.141% |
Iovance Biotherapeutics Inc. | -0.040% | 17.799% | 4.082% | 109.285% | 66.560% | -44.518% | - |
Ironwood Pharmaceuticals | 0.680% | 2.069% | -1.333% | -23.711% | -27.451% | -18.681% | - |
Ligand Pharmaceuticals | -1.450% | 2.256% | -5.556% | -6.207% | 4.615% | -35.207% | -38.462% |
Loxo Oncology Inc | - | - | - | - | - | - | - |
Medicines Co. | - | - | - | - | - | - | - |